 |
Previous Article | Next Article 
The Journal of Neuroscience, December 15, 2000, 20(24):9284-9289
Cannabinoid Withdrawal Syndrome Is Reduced in
Pre-Proenkephalin Knock-Out Mice
Olga
Valverde1,
Rafael
Maldonado1,
Emmanuel
Valjent1,
Anne M.
Zimmer2, and
Andreas
Zimmer2
1 Laboratori de Neuropharmacologia, Facultat de
Ciéncies de la Salut i de la Vida, Universidat Pompeu Fabra,
08003 Barcelona, Spain, and 2 Laboratory of Genetics,
National Institute of Mental Health, Bethesda, Maryland 20892
The functional interactions between the endogenous
cannabinoid and opioid systems were evaluated in
pre-proenkephalin-deficient mice. Antinociception induced in the
tail-immersion test by acute 9-tetrahydrocannabinol was reduced in
mutant mice, whereas no difference between genotypes was observed in
the effects induced on body temperature, locomotion, or ring catalepsy.
During a chronic treatment with 9-tetrahydrocannabinol, the
development of tolerance to the analgesic responses induced by
this compound was slower in mice lacking enkephalin. In addition,
cannabinoid withdrawal syndrome, precipitated in
9-tetrahydrocannabinol-dependent mice by the injection of SR141716A,
was significantly attenuated in mutant mice. These results indicate
that the endogenous enkephalinergic system is involved in the
antinociceptive responses of 9-tetrahydrocannabinol and participates
in the expression of cannabinoid abstinence.
Key words:
cannabinoid; opioid; mice; mutation; withdrawal; addiction; tolerance
Copyright © 2000 Society for Neuroscience 0270-6474/00/20249284-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Y. Hayashi, M. Yamamoto, H. Mizoguchi, C. Watanabe, R. Ito, S. Yamamoto, X.-y. Sun, and Y. Murata
Mice Deficient for Glucagon Gene-Derived Peptides Display Normoglycemia and Hyperplasia of Islet {alpha}-Cells But Not of Intestinal L-Cells
Mol. Endocrinol.,
December 1, 2009;
23(12):
1990 - 1999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Hoffman, M. Oz, T. Caulder, and C. R. Lupica
Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure
J. Neurosci.,
June 15, 2003;
23(12):
4815 - 4820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Sipe, K. Chiang, A. L. Gerber, E. Beutler, and B. F. Cravatt
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
PNAS,
June 11, 2002;
99(12):
8394 - 8399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Maldonado and F. Rodriguez de Fonseca
Cannabinoid Addiction: Behavioral Models and Neural Correlates
J. Neurosci.,
May 1, 2002;
22(9):
3326 - 3331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ghozland, H. W. D. Matthes, F. Simonin, D. Filliol, B. L. Kieffer, and R. Maldonado
Motivational Effects of Cannabinoids Are Mediated by {micro}-Opioid and kappa -Opioid Receptors
J. Neurosci.,
February 1, 2002;
22(3):
1146 - 1154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zimmer, E. Valjent, M. Konig, A. M. Zimmer, P. Robledo, H. Hahn, O. Valverde, and R. Maldonado
Absence of Delta -9-Tetrahydrocannabinol Dysphoric Effects in Dynorphin-Deficient Mice
J. Neurosci.,
December 1, 2001;
21(23):
9499 - 9505.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Lichtman, S. M. Sheikh, H. H. Loh, and B. R. Martin
Opioid and Cannabinoid Modulation of Precipitated Withdrawal in Delta 9-Tetrahydrocannabinol and Morphine-Dependent Mice
J. Pharmacol. Exp. Ther.,
September 1, 2001;
298(3):
1007 - 1014.
[Abstract]
[Full Text]
|
 |
|
|

|